PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.
Nat Commun. 2020 May 1;11(1):2135. doi: 10.1038/s41467-020-15959-6.
Nat Commun. 2020.
PMID: 32358509
Free PMC article.